The UFC's independent anti-doping agency has handed down another suspension to a competitor. A UFC flyweight fighter will be sidelined for several months. Combat Sports Anti-Doping (CSAD), the organization's independent anti-doping agency, announced that Alibeg Idris has accepted a one-year suspension for using a prohibited substance.
Idris tested positive for hydrochlorothiazide, a diuretic banned at all times under the UFC's Prohibited List in the 'Diuretics and Masking Agents' category. The sample was collected on February 21st, the same day he secured a unanimous decision victory over Ode Osbourne at UFC Houston. Consequently, the fight result has been overturned to a 'No Contest' by the Texas Department of Licensing and Regulation.
According to CSAD, upon notification of the positive test, Idris admitted to using hydrochlorothiazide to make weight for his bout with Osbourne. Despite his cooperation, CSAD imposed the 12-month sanction due to the "seriousness of the intentional use of a diuretic during fight week and the competitive advantage gained in reaching the agreed-upon weight."
Idris, a participant in Season 33 of The Ultimate Fighter, will be eligible to return to competition on February 21, 2027.